Lactate limits CNS autoimmunity by stabilizing HIF-1α in dendritic cells.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 09 11 2021
accepted: 06 07 2023
medline: 25 8 2023
pubmed: 10 8 2023
entrez: 9 8 2023
Statut: ppublish

Résumé

Dendritic cells (DCs) have a role in the development and activation of self-reactive pathogenic T cells

Identifiants

pubmed: 37558878
doi: 10.1038/s41586-023-06409-6
pii: 10.1038/s41586-023-06409-6
doi:

Substances chimiques

HIF1A protein, human 0
Hypoxia-Inducible Factor 1, alpha Subunit 0
Lactic Acid 33X04XA5AT
NDUFA4L2 protein, human 0
Reactive Oxygen Species 0
XBP1 protein, human 0
Lactase EC 3.2.1.108

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

881-889

Subventions

Organisme : NINDS NIH HHS
ID : R00 NS114111
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH130458
Pays : United States

Commentaires et corrections

Type : UpdateOf
Type : CommentIn

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Nature Limited.

Références

Anderson, D. A.III, Dutertre, C. A., Ginhoux, F. & Murphy, K. M. Genetic models of human and mouse dendritic cell development and function. Nat. Rev. Immunol. 21, 101–115 (2021).
pubmed: 32908299 doi: 10.1038/s41577-020-00413-x
Cabeza-Cabrerizo, M., Cardoso, A., Minutti, C. M., Pereira da Costa, M. & Reis, E. S. C. Dendritic cells revisited. Annu. Rev. Immunol. 39, 131–166 (2021).
pubmed: 33481643 doi: 10.1146/annurev-immunol-061020-053707
Nasser, J. et al. Genome-wide enhancer maps link risk variants to disease genes. Nature 593, 238–243 (2021).
pubmed: 33828297 pmcid: 9153265 doi: 10.1038/s41586-021-03446-x
Saevarsdottir, S. et al. FLT3 stop mutation increases FLT3 ligand level and risk of autoimmune thyroid disease. Nature 584, 619–623 (2020).
pubmed: 32581359 doi: 10.1038/s41586-020-2436-0
Dixon, K. O. et al. TIM-3 restrains anti-tumour immunity by regulating inflammasome activation. Nature 595, 101–106 (2021).
pubmed: 34108686 pmcid: 8627694 doi: 10.1038/s41586-021-03626-9
Ferris, S. T. et al. cDC1 prime and are licensed by CD4
pubmed: 32788723 pmcid: 7469755 doi: 10.1038/s41586-020-2611-3
Buck, M. D., Sowell, R. T., Kaech, S. M. & Pearce, E. L. Metabolic instruction of immunity. Cell 169, 570–586 (2017).
Du, X. et al. Hippo/Mst signalling couples metabolic state and immune function of CD8α
pubmed: 29849151 pmcid: 6292204 doi: 10.1038/s41586-018-0177-0
Campbell, C. et al. Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells. Nature 581, 475–479 (2020).
pubmed: 32461639 pmcid: 7540721 doi: 10.1038/s41586-020-2193-0
Suez, J., Zmora, N., Segal, E. & Elinav, E. The pros, cons, and many unknowns of probiotics. Nat. Med. 25, 716–729 (2019).
pubmed: 31061539 doi: 10.1038/s41591-019-0439-x
Buffington, S. A. et al. Dissecting the contribution of host genetics and the microbiome in complex behaviors. Cell 184, 1740–1756 (2021).
pubmed: 33705688 pmcid: 8996745 doi: 10.1016/j.cell.2021.02.009
Canale, F. P. et al. Metabolic modulation of tumours with engineered bacteria for immunotherapy. Nature 598, 662–666 (2021).
pubmed: 34616044 doi: 10.1038/s41586-021-04003-2
Scott, B. M. et al. Self-tunable engineered yeast probiotics for the treatment of inflammatory bowel disease. Nat. Med. 27, 1212–1222 (2021).
pubmed: 34183837 doi: 10.1038/s41591-021-01390-x
Colegio, O. R. et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature 513, 559–563 (2014).
pubmed: 25043024 pmcid: 4301845 doi: 10.1038/nature13490
Benoun, J. M. et al. Optimal protection against Salmonella infection requires noncirculating memory. Proc. Natl Acad. Sci. USA 115, 10416–10421 (2018).
pubmed: 30254173 pmcid: 6187142 doi: 10.1073/pnas.1808339115
Tannahill, G. M. et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature 496, 238–242 (2013).
pubmed: 23535595 pmcid: 4031686 doi: 10.1038/nature11986
Safran, M. et al. Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity: assessment of an oral agent that stimulates erythropoietin production. Proc. Natl Acad. Sci. USA 103, 105–110 (2006).
pubmed: 16373502 doi: 10.1073/pnas.0509459103
Bosshart, P. D., Kalbermatter, D., Bonetti, S. & Fotiadis, D. Mechanistic basis of L-lactate transport in the SLC16 solute carrier family. Nat. Commun. 10, 2649 (2019).
pubmed: 31201333 pmcid: 6573034 doi: 10.1038/s41467-019-10566-6
Brown, T. P. et al. The lactate receptor GPR81 promotes breast cancer growth via a paracrine mechanism involving antigen-presenting cells in the tumor microenvironment. Oncogene 39, 3292–3304 (2020).
pubmed: 32071396 doi: 10.1038/s41388-020-1216-5
Levitt, M. D. & Levitt, D. G. Quantitative evaluation of D-lactate pathophysiology: new insights into the mechanisms involved and the many areas in need of further investigation. Clin. Exp. Gastroenterol. 13, 321–337 (2020).
pubmed: 32982363 pmcid: 7490090 doi: 10.2147/CEG.S260600
Colgan, S. P., Furuta, G. T. & Taylor, C. T. Hypoxia and innate immunity: keeping up with the HIFsters. Annu. Rev. Immunol. 38, 341–363 (2020).
pubmed: 31961750 pmcid: 7924528 doi: 10.1146/annurev-immunol-100819-121537
Tello, D. et al. Induction of the mitochondrial NDUFA4L2 protein by HIF-1α decreases oxygen consumption by inhibiting complex I activity. Cell Metab. 14, 768–779 (2011).
Mogilenko, D. A. et al. Metabolic and innate immune cues merge into a specific inflammatory response via the UPR. Cell 177, 1201–1216 (2019).
pubmed: 31031005 doi: 10.1016/j.cell.2019.03.018
Martinez-Reyes, I. & Chandel, N. S. Mitochondrial TCA cycle metabolites control physiology and disease. Nat. Commun. 11, 102 (2020).
pubmed: 31900386 pmcid: 6941980 doi: 10.1038/s41467-019-13668-3
Martinon, F., Chen, X., Lee, A. H. & Glimcher, L. H. TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages. Nat. Immunol. 11, 411–418 (2010).
pubmed: 20351694 pmcid: 3113706 doi: 10.1038/ni.1857
Cubillos-Ruiz, J. R. et al. ER stress sensor XBP1 controls anti-tumor immunity by disrupting dendritic cell homeostasis. Cell 161, 1527–1538 (2015).
pubmed: 26073941 pmcid: 4580135 doi: 10.1016/j.cell.2015.05.025
Puurunen, M. K. et al. Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1/2a study. Nat. Metab. 3, 1125–1132 (2021).
pubmed: 34294923 doi: 10.1038/s42255-021-00430-7
Kurtz, C. B. et al. An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans. Sci. Transl. Med. 11, eaau7975 (2019).
pubmed: 30651324 doi: 10.1126/scitranslmed.aau7975
Castano-Cerezo, S. et al. An insight into the role of phosphotransacetylase (pta) and the acetate/acetyl-CoA node in Escherichia coli. Microb. Cell Fact. 8, 54 (2009).
pubmed: 19852855 pmcid: 2774668 doi: 10.1186/1475-2859-8-54
Enjalbert, B., Millard, P., Dinclaux, M., Portais, J. C. & Letisse, F. Acetate fluxes in Escherichia coli are determined by the thermodynamic control of the Pta–AckA pathway. Sci. Rep. 7, 42135 (2017).
pubmed: 28186174 pmcid: 5301487 doi: 10.1038/srep42135
Berer, K. et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 479, 538–541 (2011).
pubmed: 22031325 doi: 10.1038/nature10554
Hiltensperger, M. et al. Skin and gut imprinted helper T cell subsets exhibit distinct functional phenotypes in central nervous system autoimmunity. Nat. Immunol. 22, 880–892 (2021).
pubmed: 34099917 pmcid: 7611097 doi: 10.1038/s41590-021-00948-8
Schnell, A. et al. Stem-like intestinal Th17 cells give rise to pathogenic effector T cells during autoimmunity. Cell 184, 6281–6298 (2021).
pubmed: 34875227 pmcid: 8900676 doi: 10.1016/j.cell.2021.11.018
Tomura, M. et al. Monitoring cellular movement in vivo with photoconvertible fluorescence protein “Kaede” transgenic mice. Proc. Natl Acad. Sci. USA 105, 10871–10876 (2008).
pubmed: 18663225 pmcid: 2504797 doi: 10.1073/pnas.0802278105
D’Ignazio, L., Bandarra, D. & Rocha, S. NF-κB and HIF crosstalk in immune responses. FEBS J. 283, 413–424 (2016).
pubmed: 26513405 doi: 10.1111/febs.13578
O’Neill, L. A., Kishton, R. J. & Rathmell, J. A guide to immunometabolism for immunologists. Nat. Rev. Immunol. 16, 553–565 (2016).
pubmed: 27396447 pmcid: 5001910 doi: 10.1038/nri.2016.70
Aste-Amezaga, M., Ma, X., Sartori, A. & Trinchieri, G. Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10. J. Immunol. 160, 5936–5944 (1998).
pubmed: 9637507 doi: 10.4049/jimmunol.160.12.5936
Mascanfroni, I. D. et al. IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39. Nat. Immunol. 14, 1054–1063 (2013).
pubmed: 23995234 pmcid: 3964005 doi: 10.1038/ni.2695
Lawless, S. J. et al. Glucose represses dendritic cell-induced T cell responses. Nat. Commun. 8, 15620 (2017).
pubmed: 28555668 pmcid: 5459989 doi: 10.1038/ncomms15620
Zhang, D. et al. Metabolic regulation of gene expression by histone lactylation. Nature 574, 575–580 (2019).
pubmed: 31645732 pmcid: 6818755 doi: 10.1038/s41586-019-1678-1
Cheng, S. C. et al. mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity. Science 345, 1250684 (2014).
pubmed: 25258083 pmcid: 4226238 doi: 10.1126/science.1250684
Watson, M. J. et al. Metabolic support of tumour-infiltrating regulatory T cells by lactic acid. Nature 591, 645–651 (2021).
pubmed: 33589820 pmcid: 7990682 doi: 10.1038/s41586-020-03045-2
Sanmarco, L. M. et al. Identification of environmental factors that promote intestinal inflammation. Nature 611, 801–809 (2022).
pubmed: 36266581 pmcid: 9898826 doi: 10.1038/s41586-022-05308-6
Schiering, C. et al. Feedback control of AHR signalling regulates intestinal immunity. Nature 542, 242–245 (2017).
pubmed: 28146477 pmcid: 5302159 doi: 10.1038/nature21080
Opitz, C. A. et al. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature 478, 197–203 (2011).
pubmed: 21976023 doi: 10.1038/nature10491
Takenaka, M. C. et al. Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39. Nat. Neurosci. 22, 729–740 (2019).
pubmed: 30962630 pmcid: 8052632 doi: 10.1038/s41593-019-0370-y
Rothhammer, V. & Quintana, F. J. The aryl hydrocarbon receptor: an environmental sensor integrating immune responses in health and disease. Nat. Rev. Immunol. 19, 184–197 (2019).
pubmed: 30718831 doi: 10.1038/s41577-019-0125-8
Mascanfroni, I. D. et al. Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-α. Nat. Med. 21, 638–646 (2015).
pubmed: 26005855 pmcid: 4476246 doi: 10.1038/nm.3868
Kenison, J. E. et al. Tolerogenic nanoparticles suppress central nervous system inflammation. Proc. Natl Acad. Sci. USA 117, 32017–32028 (2020).
pubmed: 33239445 pmcid: 7749362 doi: 10.1073/pnas.2016451117
Krienke, C. et al. A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis. Science 371, 145–153 (2021).
pubmed: 33414215 doi: 10.1126/science.aay3638
Bettelli, E. et al. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 197, 1073–1081 (2003).
pubmed: 12732654 pmcid: 2193967 doi: 10.1084/jem.20021603
Sanmarco, L. M. et al. Gut-licensed IFNγ
pubmed: 33408417 pmcid: 8039910 doi: 10.1038/s41586-020-03116-4
Wheeler, M. A. et al. MAFG-driven astrocytes promote CNS inflammation. Nature 578, 593–599 (2020).
pubmed: 32051591 pmcid: 8049843 doi: 10.1038/s41586-020-1999-0
Eberhardt, N. et al. Deficiency of CD73 activity promotes protective cardiac immunity against Trypanosoma cruzi infection but permissive environment in visceral adipose tissue. Biochim. Biophys. Acta Mol. Basis Dis. 1866, 165592 (2020).
pubmed: 31678157 doi: 10.1016/j.bbadis.2019.165592
Wheeler, M. A. et al. Environmental control of astrocyte pathogenic activities in CNS inflammation. Cell 176, 581–596 (2019).
pubmed: 30661753 pmcid: 6440749 doi: 10.1016/j.cell.2018.12.012
Leventhal, D. S. et al. Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity. Nat. Commun. 11, 2739 (2020).
pubmed: 32483165 pmcid: 7264239 doi: 10.1038/s41467-020-16602-0
Trombetta, J. J. et al. Preparation of single-cell RNA-seq libraries for next generation sequencing. Curr. Protoc. Mol. Biol. 107, 4.22.1–4.22.17 (2014).
pubmed: 24984854 doi: 10.1002/0471142727.mb0422s107
Bray, N. L., Pimentel, H., Melsted, P. & Pachter, L. Near-optimal probabilistic RNA-seq quantification. Nat. Biotechnol. 34, 525–527 (2016).
pubmed: 27043002 doi: 10.1038/nbt.3519
Patro, R., Duggal, G., Love, M. I., Irizarry, R. A. & Kingsford, C. Salmon provides fast and bias-aware quantification of transcript expression. Nat. Methods 14, 417–419 (2017).
pubmed: 28263959 pmcid: 5600148 doi: 10.1038/nmeth.4197
Zhu, A., Ibrahim, J. G. & Love, M. I. Heavy-tailed prior distributions for sequence count data: removing the noise and preserving large differences. Bioinformatics 35, 2084–2092 (2019).
pubmed: 30395178 doi: 10.1093/bioinformatics/bty895
Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545–15550 (2005).
pubmed: 16199517 pmcid: 1239896 doi: 10.1073/pnas.0506580102
Mootha, V. K. et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267–273 (2003).
pubmed: 12808457 doi: 10.1038/ng1180
Illouz, T., Madar, R., Hirsh, T., Biragyn, A. & Okun, E. Induction of an effective anti-Amyloid-β humoral response in aged mice. Vaccine 39, 4817–4829 (2021).
pubmed: 34294479 pmcid: 9237638 doi: 10.1016/j.vaccine.2021.07.023
Illouz, T. et al. Maternal antibodies facilitate Amyloid-β clearance by activating Fc-receptor-Syk-mediated phagocytosis. Commun. Biol. 4, 329 (2021).
pubmed: 33712740 pmcid: 7955073 doi: 10.1038/s42003-021-01851-6
Haralick, R. M. & Shapiro, L. G. in Computer and Robot Vision Vol. 1 (eds Haralick, R. M. & Shapiro, L. G.) 28–48 (Addison-Wesley, 1992).
Motulsky, H. J., & Brown, R. E. Detecting outliers when fitting data with nonlinear regression–a new method based on robust nonlinear regression and the false discovery rate. BMC Bioinformatics 7, 123 (2006).
pubmed: 16526949 pmcid: 1472692 doi: 10.1186/1471-2105-7-123

Auteurs

Liliana M Sanmarco (LM)

Ann Romney Center for Neurologic Diseases, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.

Joseph M Rone (JM)

Ann Romney Center for Neurologic Diseases, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.
Evergrande Center for Immunologic Diseases, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.

Carolina M Polonio (CM)

Ann Romney Center for Neurologic Diseases, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.

Gonzalo Fernandez Lahore (G)

Ann Romney Center for Neurologic Diseases, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.
Evergrande Center for Immunologic Diseases, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.

Federico Giovannoni (F)

Ann Romney Center for Neurologic Diseases, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.

Kylynne Ferrara (K)

Ann Romney Center for Neurologic Diseases, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.

Cristina Gutierrez-Vazquez (C)

Ann Romney Center for Neurologic Diseases, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.

Ning Li (N)

Synlogic Therapeutics, Cambridge, MA, USA.

Anna Sokolovska (A)

Synlogic Therapeutics, Cambridge, MA, USA.

Agustin Plasencia (A)

Ann Romney Center for Neurologic Diseases, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.

Camilo Faust Akl (C)

Ann Romney Center for Neurologic Diseases, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.

Payal Nanda (P)

Ann Romney Center for Neurologic Diseases, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.

Evelin S Heck (ES)

Ann Romney Center for Neurologic Diseases, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.

Zhaorong Li (Z)

Ann Romney Center for Neurologic Diseases, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.

Hong-Gyun Lee (HG)

Ann Romney Center for Neurologic Diseases, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.

Chun-Cheih Chao (CC)

Ann Romney Center for Neurologic Diseases, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.

Claudia M Rejano-Gordillo (CM)

Ann Romney Center for Neurologic Diseases, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.

Pedro H Fonseca-Castro (PH)

Ann Romney Center for Neurologic Diseases, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.

Tomer Illouz (T)

Ann Romney Center for Neurologic Diseases, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.

Mathias Linnerbauer (M)

Ann Romney Center for Neurologic Diseases, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.

Jessica E Kenison (JE)

Ann Romney Center for Neurologic Diseases, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.

Rocky M Barilla (RM)

Ann Romney Center for Neurologic Diseases, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.
Evergrande Center for Immunologic Diseases, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.

Daniel Farrenkopf (D)

Ann Romney Center for Neurologic Diseases, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.

Nikolas A Stevens (NA)

Ann Romney Center for Neurologic Diseases, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.

Gavin Piester (G)

Ann Romney Center for Neurologic Diseases, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.

Elizabeth N Chung (EN)

Ann Romney Center for Neurologic Diseases, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.

Lucas Dailey (L)

Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Vijay K Kuchroo (VK)

Ann Romney Center for Neurologic Diseases, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.
Evergrande Center for Immunologic Diseases, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.

David Hava (D)

Synlogic Therapeutics, Cambridge, MA, USA.

Michael A Wheeler (MA)

Ann Romney Center for Neurologic Diseases, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.
Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Clary Clish (C)

Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Roni Nowarski (R)

Ann Romney Center for Neurologic Diseases, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.
Evergrande Center for Immunologic Diseases, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.

Eduardo Balsa (E)

Centro de Biología Molecular Severo Ochoa UAM-CSIC, Universidad Autónoma de Madrid, Madrid, Spain.

Jose M Lora (JM)

Synlogic Therapeutics, Cambridge, MA, USA.

Francisco J Quintana (FJ)

Ann Romney Center for Neurologic Diseases, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA. fquintana@rics.bwh.harvard.edu.
Broad Institute of MIT and Harvard, Cambridge, MA, USA. fquintana@rics.bwh.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH